The shelf effectiveness unlocks immediate resale of shares by warrant holders, creating severe supply overhang for a micro-cap with thin liquidity. Expect continued downward pressure; monitor for any takedown announcements or additional cash burn updates. The cross-filing context shows this is the precise mechanism of the previously bearish S-3 — no change in thesis.
Price Chart
Executive Summary
The SEC declared effective the S-3 shelf registration (File No. 333-296866) for Bluejay Diagnostics, Inc., covering the resale of 11,223,665 common shares issuable upon warrant exercise from the June 2026 private placement. With only ~1.03 million shares currently outstanding, this represents potential dilution of over 1,000% and creates immediate overhang for a pre-revenue, going-concern company with just $3.68M cash.
Key Facts
- S-3 shelf registration 333-296866 declared effective as of 2026-06-26.
- Shelf covers 11,223,665 shares of common stock for resale by selling stockholders.
- Shares are issuable upon exercise of warrants from the June 2026 private placement.
- Potential dilution of over 1,000% relative to ~1.03 million shares outstanding.
- Company remains pre-revenue with going concern risk and only $3.68M cash as of March 31, 2026.
- Market cap is approximately $3M, making dilution risk acute.
Financial Impact
Potential dilution of 1,000%+ from 11.2M registered shares vs. ~1.03M shares outstanding. Company had $3.68M cash as of March 31, 2026, with no revenue.
Risk Factors
- Immediate dilutive selling by warrant holders post-effectiveness.
- Pre-revenue status with going concern risk and limited cash runway.
- Extreme share count increase could trigger Nasdaq non-compliance or further equity erosion.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002139 |
| Document: 9999999995-26-002139-index.html | 9999999995-26-002139 |
| Document: 9999999995-26-002139.txt | 9999999995-26-002139 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 8-K | $0.8323 | awaiting T+20 | — | $0.5770 (−30.67%) |
Oct 6, 2026 21d ago | 8-K | $0.8107 | awaiting T+20 | — | $0.5770 (−28.83%) |
Aug 13, 2026 10w ago | 8-K | $1.06 | awaiting T+20 | — | $0.5770 (−45.57%) |
Aug 13, 2026 10w ago | Press Release | $1.06 | awaiting T+20 | — | $0.5770 (−45.57%) |
Jul 22, 2026 13w ago | 8-K | $1.14 $0.9393 | ▼ −17.61% | ▼ −20.91% | $0.5770 (−49.39%) |
Jul 13, 2026 15w ago | 3 | $1.22 $0.9872 | ▼ −19.08% | ▼ −22.27% | $0.5770 (−52.70%) |
Jul 10, 2026 15w ago | 3 | $1.45 $1.07 | ▼ −26.21% | ▼ −28.63% | $0.5770 (−60.21%) |
Jun 29, 2026 17w ago | EFFECT | $1.44 $1.03 | ▲ +28.47% | ▲ +28.19% | $0.5770 (+59.93%) |
Jun 17, 2026 18w ago | S-3 | $4.46 $1.30 | ▲ +70.85% | ▲ +71.39% | $0.5770 (+87.06%) |
Jun 9, 2026 20w ago | 8-K | $4.49 $1.40 | ▼ −68.82% | ▼ −72.44% | $0.5770 (−87.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers